WEBINARS
Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
Show More
-
OCTOBER 19, 2023 2:00 PM ET
Discuss ways to visualize cellular viability and fluorescence applications.... -
OCT 19, 2023 | 10:00 AM
Introducing the new CytoScan HD Accel microarray that significantly improves the power and speed of genome-wide copy number analysis using industry-leading Chromosomal Microarray (CMA). The...
-
OCT 19, 2023 | 12:00 PM
Introducing the new CytoScan HD Accel microarray that significantly improves the power and speed of genome-wide copy number analysis using industry-leading Chromosomal Microarray (CMA). The...
-
OCT 18, 2023 | 9:00 AM
In this webinar, Jenny Meredith, Ph.D., HCLD(ABB), Clinical Microbiology Director at Prisma Health-Upstate joins forces with Sara Ezra, Molecular Supervisor at Pathology Consultants (subsidi...
-
OCT 17, 2023 | 6:00 AM
During this presentation, the speaker will provide insights into the clinical utility of the T2Bacteria and T2Resistance Panels in the intensive care unit (ICU), including real-world clinica...
-
OCT 17, 2023 | 9:00 AM
Introducing the new CytoScan HD Accel microarray that significantly improves the power and speed of genome-wide copy number analysis using industry-leading Chromosomal Microarray (CMA). The...
-
OCT 16, 2023 | 9:00 AM
Clarification of mammalian and bacterial cell broths can be challenging when it comes to managing filter capacity and maximizing product recovery. Body feed filtration is an innovative techn...
-
OCTOBER 12, 2023 2:00 PM ET
Discuss how there are various ways to collect cells for cell therapy and then go into how our blood collection items can be a part of that solution....
-
OCT 12, 2023 | 9:00 AM
Multicolor flow cytometry is beneficial because it allows us to gain deeper insights from a given biological sample, with fewer repeat markers in each tube and quicker results. In this three...
-
OCT 12, 2023 | 10:00 AM
Next-generation sequencing (NGS) has become increasingly popular with testing labs, as it allows them to obtain more data in less time and with minimal input. In this webinar, we will explor...
OCT 12, 2023 | 8:00 AM
Patient-derived tumoroids, also known as cancer organoids, hold potential as cost-effective models for cancer immunotherapy research. Patient-derived tumor models, which mimic the tumor micr...
OCT 12, 2023 | 6:00 AM
Acute coughing is one of the most common reasons for consulting in primary care thus driving considerable antibiotic use and health-care costs. Currently, identification of microbial etiolog...
OCT 11, 2023 | 9:00 PM
Epigenetic modifications such as DNA methylation have long shown promise as potential biomarkers to diagnose and guide treatment of many human diseases, including multiple types of cancers....
OCT 11, 2023 | 7:00 AM
Embark on an enlightening journey through the intricate landscape of loop-mediated isothermal amplification (LAMP) technology. Unveil the ingenious mechanism of rapid DNA amplification under...
OCT 10, 2023 | 8:00 PM
Embark on an enlightening journey through the intricate landscape of loop-mediated isothermal amplification (LAMP) technology. Unveil the ingenious mechanism of rapid DNA amplification under...
OCT 10, 2023 | 10:00 AM
C.E. CREDITS
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...
OCT 10, 2023 | 9:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
OCT 10, 2023 | 8:00 AM
In June 2022, the ICH released the first draft of its harmonized global Drug Interaction Studies Guideline (M12). The guideline is the result of several meetings of the Expert Working Group...
OCT 10, 2023 | 1:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
OCTOBER 05, 2023 2:00 PM ET
In this session we will help you gain an understanding of a Class II BSC's role in the rapidly growing cell and gene therapy market. We will cover......
OCT 05, 2023 | 1:00 AM
C.E. CREDITS
Organoids continue to gain traction in drug discovery efforts as they offer a more biologically relevant disease model than traditional approaches. But they aren't without challenges. Jo...
OCT 04, 2023 | 10:00 AM
C.E. CREDITS
Current clinical methods used to identify epithelial ovarian cancer are often too late – when the cancer is at an advanced stage, leaving the patient with limited therapeutic options....
SEP 28, 2023 | 10:00 AM
Accurate diagnosis of H. pylori infection remains both crucial and challenging today. In line with current guidelines, confirming eradication after antibiotic treatment is essential. Diagnos...
SEP 28, 2023 | 8:00 AM
Are you studying complex biological structures such as vasculatures or neuronal networks but feel like you're not seeing the whole picture? Step into a new dimension with the UltraMicros...
SEP 28, 2023 | 7:00 AM
Webinars will be available for unlimited on-demand viewing after live event. Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the AS...
SEP 27, 2023 | 9:00 AM
Join our webinar where we will highlight key NextSeq™ 1000 and 2000 product updates and features of the on-board DRAGEN Bio-IT platform. We will cover the basics of how the flexibility...
SEP 27, 2023 | 8:00 AM
Cell therapy holds promise in improving outcomes for many difficult-to-treat diseases. However, this therapeutic strategy also comes with challenges that limit rollouts on a more impactful s...
